Exploring the Lived Experiences of Medication for Opioid use Disorder Treatment: A Qualitative Study among a Crowdsourced Convenience Sample

被引：0
作者：
Victor, Grant [1 ]
Kheibari, A. [2 ]
Strickland, J. C. [3 ]
机构：
[1] Rutgers State Univ, Sch Social Work, 120 Albany St, New Brunswick, NJ 08901 USA
[2] Wayne State Univ, Sch Social Work, 5447 Woodward Ave, Detroit, MI 48202 USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, 5510 Nathan Shock Dr, Baltimore, MD 21224 USA
来源：
COMMUNITY MENTAL HEALTH JOURNAL | 2025年 / 61卷 / 03期
基金：
美国国家卫生研究院;
关键词：
Opioid use disorder; Buprenorphine; Methadone; Treatment; Qualitative; Crowdsourcing; BUPRENORPHINE TAPER; ASSISTED TREATMENT; UNITED-STATES; THERAPY;
D O I：
10.1007/s10597-024-01345-9
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Given the effectiveness of medication for opioid use disorder (MOUD) and low engagement of treatment among people who use drugs (PWUD), it is important to better understand how to engage treatment clients with MOUD care. The current study aimed to achieve this goal by using qualitative methodology to characterize the MOUD treatment experiences. Participants (N = 52) were recruited for an online semi-structured interview. Qualitative analysis revealed varied treatment experiences, with the majority expressing irregular and intermittent MOUD treatment engagement. The therapeutic effects of MOUD in curbing withdrawal symptoms in conjunction with counseling services was frequently mentioned, as well as a preference for methadone maintenance treatment (MMT) to buprenorphine or naltrexone. Many participants described barriers to treatment and continuation of care, including failed drug screens for non-opioid drugs, perceived stigma, and physician-initiated discontinuation of treatment. The current study revealed that patients had favorable experiences with MOUD treatment, particularly when supplemented with counseling services.
引用
收藏
页码：411 / 419
页数：9
相关论文
共 58 条
  • [21] Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder
    Evans, Elizabeth A.
    Yoo, Caroline
    Huang, David
    Saxon, Andrew J.
    Hser, Yih-Ing
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2019, 106 : 19 - 28
  • [22] Primary Care-Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence A Randomized Clinical Trial
    Fiellin, David A.
    Schottenfeld, Richard S.
    Cutter, Christopher J.
    Moore, Brent A.
    Barry, Declan T.
    O'Connor, Patrick G.
    [J]. JAMA INTERNAL MEDICINE, 2014, 174 (12) : 1947 - 1954
  • [23] Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: A qualitative study of the perceptions of former inmates with opioid use disorder
    Fox A.D.
    Maradiaga J.
    Weiss L.
    Sanchez J.
    Starrels J.L.
    Cunningham C.O.
    [J]. Addiction Science & Clinical Practice, 10 (1)
  • [24] Medication-Assisted Treatment With Methadone: Assessing the Evidence
    Fullerton, Catherine Anne
    Kim, Meelee
    Thomas, Cindy Parks
    Lyman, D. Russell
    Montejano, Leslie B.
    Dougherty, Richard H.
    Daniels, Allen S.
    Ghose, Sushmita Shoma
    Delphin-Rittmon, Miriam E.
    [J]. PSYCHIATRIC SERVICES, 2014, 65 (02) : 146 - 157
  • [25] Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder
    Hadland, Scott E.
    Bagley, Sarah M.
    Rodean, Jonathan
    Silverstein, Michael
    Levy, Sharon
    Larochelle, Marc R.
    Samet, Jeffrey H.
    Zima, Bonnie T.
    [J]. JAMA PEDIATRICS, 2018, 172 (11) : 1029 - 1037
  • [26] Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study
    Hewell, Valerie M.
    Vasquez, Angel R.
    Rivkin, Inna D.
    [J]. SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2017, 12
  • [27] Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis
    Hoffman, Kim A.
    Foot, Canyon
    Levander, Ximena A.
    Cook, Ryan
    Terashima, Javier Ponce
    McIlveen, John W.
    Korthuis, P. Todd
    McCarty, Dennis
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2022, 141
  • [28] Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States
    Huhn, Andrew S.
    Hobelmann, J. Gregory
    Strickland, Justin C.
    Oyler, George A.
    Bergeria, Cecilia L.
    Umbricht, Annie
    Dunn, Kelly E.
    [J]. JAMA NETWORK OPEN, 2020, 3 (02)
  • [29] Time Constraints in the Alcohol Purchase Task
    Kaplan, Brent A.
    Reed, Derek D.
    Murphy, James G.
    Henley, Amy J.
    Reed, Florence D. DiGennaro
    Roma, Peter G.
    Hursh, Steven R.
    [J]. EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2017, 25 (03) : 186 - 197
  • [30] Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings
    Krawczyk, Noa
    Williams, Arthur Robin
    Saloner, Brendan
    Cerda, Magdalena
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2021, 126
123456